Aviance Capital Management’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-21,581
| Closed | -$844K | – | 211 |
|
|
2016
Q4 | $844K | Sell |
21,581
-3,838
| -15% | -$150K | 0.04% | 132 |
|
|
2016
Q3 | $1.12M | Sell |
25,419
-6,192
| -20% | -$274K | 0.03% | 200 |
|
|
2016
Q2 | $1.32M | Sell |
31,611
-1,032
| -3% | -$43.1K | 0.04% | 179 |
|
|
2016
Q1 | $1.31M | Buy |
32,643
+1,060
| +3% | +$42.7K | 0.04% | 152 |
|
|
2015
Q4 | $1.62M | Buy |
31,583
+4,081
| +15% | +$209K | 0.05% | 138 |
|
|
2015
Q3 | $1.29M | Buy |
+27,502
| New | +$1.29M | 0.05% | 141 |
|
|
2015
Q2 | – | Sell |
-14,028
| Closed | -$866K | – | 251 |
|
|
2015
Q1 | $866K | Buy |
14,028
+1,078
| +8% | +$66.5K | 0.03% | 152 |
|
|
2014
Q4 | $699K | Buy |
12,950
+1,366
| +12% | +$73.7K | 0.03% | 192 |
|
|
2014
Q3 | $614K | Buy |
11,584
+2,636
| +29% | +$140K | 0.02% | 213 |
|
|
2014
Q2 | $464K | Buy |
+8,948
| New | +$464K | 0.02% | 234 |
|